pOly(l-lactide glycOlide) cas 30846-39-0

Chemical Name:POLY(L-LACTIDE GLYCOLIDE)

CAS No.:30846-39-0

Molecular Formula:(C6H8O4)x.(C4H4O4)x

Appearance: White or pale yellow floccules or powder or particles

分类:

描述

POLY(L-LACTIDE GLYCOLIDE) Details

Chemical Name:POLY(L-LACTIDE GLYCOLIDE)

CAS No.:30846-39-0

Molecular Formula:(C6H8O4)x.(C4H4O4)x

Appearance: White or pale yellow floccules or powder or particles

POLY(L-LACTIDE GLYCOLIDE) Typical Properties

Item Specifications Results
State of nature White or pale yellow floccules or powder or particles . No other material . No obvious smell Qualified
Material identification 1H-NMR the characteristic peal of nuclear magnetic resonance (NMR ) spectroscopy test should be anastomotic YY/T 0661-2017 or YY/T 0510-2009 Qualified
DL-LA : GA 80-90 mol% : 10-20 mol% Qualified
50 mol% : 50 mol%
Intrinsic Viscosity 0.5–0.75 dl/g Qualified
Residual Solvent < 0.5 % Qualified
Heavy Metals < 10 ppm Qualified
Sulphated Ash < 0.1 % Qualified
Conclusion The results conforms with Q/PT 0401﹣2013

POLY(L-LACTIDE GLYCOLIDE) Usage

1.Used in surgical sutures, anti-adhesion membranes and tissue engineering scaffolds.

2.Compared with PLA, polymer degradation time can be controlled according to different GA content, and the material is soft and elastic.

3.Different types of PDLGA can be prepared in different monomer ratios, for example: PDLGA 75:25 means that the polymer consists of 75% lactic acid and 25% glycolic acid. The degree of degradation of PDLGA varies with monomer ratio, and the larger the proportion of glycolide, the more easily it degrades.

4.Used as a medical surgical film, skin transplantation, wound suturing, microcapsule for injection, in vivo implantation, micro Excipients for sustained-release preparations and porous scaffolds for tissue engineering cell culture

POLY(L-LACTIDE GLYCOLIDE) Packaging and Shipping

Packing: 25kg/ drum

Delivery: within 15-30 working days

POLY(L-LACTIDE GLYCOLIDE) Storage

Stored at room temperature

返回顶部